Lisa DeFrancesco | executive |
Lonnel Coats | executive |
Jeffrey Wade | executive |
Tom Garner | executive |
Craig Granowitz | executive |
John Geelan | analyst |
Alan Main | executive |
Roanna Clarissa Ruiz | analyst |
Lin Tsai | analyst |
Joseph Stringer | analyst |
Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, May 2, 2024. I'll now turn the call over to Lisa DeFrancesco, Head of Investor Relations and Strategy for Lexicon. Please go ahead, Lisa.
Thank you, Jamie. Good afternoon, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call.